Trial Profile
A Phase 1 Open-label Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a Single Dose of ASP3652 in Caucasian, Japanese, Black/African and Chinese Healthy Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs ASP 3652 (Primary)
- Indications Interstitial cystitis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma BV
- 14 Oct 2013 New trial record